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ABSTRACT  
Pulmonary embolism (PE) is a major diagnostic challenge facing emergency 
medicine physicians. It affects over 900,000 patients every year. Only two-thirds of 
the patients affected are alive one month after the diagnosis, while only half live to 
about a year.   
 
The exact aetiology is not known, but several risk factors have been implicated in the 
aetio-pathogenesis of the disease. Furthermore, as this disease has no definitive 
symptoms or signs, the diagnosis in patients suspected of harbouring a PE is only 
confirmed or excluded after special investigations.  
 
Although anticoagulation is an effective treatment, it has its inherent side-effects and 
associated morbidity. Thus, it is prudent to utilize clinical scoring systems to direct 
diagnostic pathways prior to instituting treatment. In this regard, several clinical 
decisions have been promoted to assist physicians in the workup of a patient with 
hypoxia. One well advocated rule is the Wells criteria, which consists of seven 
components, each of which is given a score. All the scores are then added up to give 
a total, i.e. the Wells score. Based on the Wells score, the clinician is then able to 
assign a clinical pre-test probability of the patient having PE – i.e. low, medium or 
high risk.  
 
Although a pulmonary angiography offers the only definitive means of establishing a 
diagnosis of PE, it is not practical to employ such an invasive and expensive 
technique as a screening test. The V/Q scan has been widely used instead; and, has 
been shown to be an effective non-invasive procedure for the detection of PE.  
 
Patients referred for a ventilation-perfusion scan (V/Q scan) are categorised as 
having no typical evidence of PE, or very low probability, low probability, 
intermediate probability or high probability of having a PE.  
 
Objective: The study set out to determine the correlation between the probability 
given by the Wells score and the probability obtained from the V/Q scan results.  
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Methods: The study entails a retrospective analysis of 120 adult patients (>18 years 
of age), who were referred for a V/Q scan for suspected pulmonary embolism at 
Charlotte Maxeke Johannesburg Academic Hospital and Chris Hani Baragwanath 
Academic Hospital over a 16 month period.  
 
Clinical notes were obtained to ascertain risk factors, presenting symptoms and 
other data to determine pre-test probability of having a pulmonary embolus. This pre-
test probability was categorised according to the Wells score into low, moderate or 
high risk to provide a more objective measure. The V/Q scan results were obtained 
from the Nuclear Medicine Department at the health care facility, and these results 
were subsequently compared to the Wells score in order to establish a correlation 
between the two parameters, i.e. pre-test probability vs V/Q scan results. 
 
Results: The sample population comprised of patients from various age groups, 
ranging from 18 years to 86 years of age. The median age was 55 years, with almost 
half of the patients being in the 6th and 7th decades of life. 
 
Significant risk factors in our setting were found to be advanced age, history of 
immobilisation and acute medical illnesses. In the younger population, a history of 
immobilisation due to trauma or post surgery, and HIV/AIDS were found to be the 
most significant risk factors.  
 
Based on the history, and presenting signs and symptoms, all the patients were 
initially categorised into low, moderate or high pre-test probability based on the Wells 
score. The majority of the patients were categorised as moderate risk (59%). Thirty 
percent (36 patients) were categorised as low risk, and the remainder (11%) as high 
risk for having a PE. 
 
On the V/Q scan results, a total of 74% of patients scanned fell into the low 
probability, very low probability or no typical evidence category. For the purposes of 
statistical analysis, these three categories were combined into one category, labelled 
simply as low probability. Thirteen percent of the patients were classified as 
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intermediate probability and the remaining thirteen percent as high probability on the 
V/Q scan. 
 
On analysis of the data, 80% of patients that were initially categorised as low risk 
based on the Wells score were also classified as low probability on the V/Q scan 
results (this category included the low probability, very low probability or no typical 
evidence categories as mentioned earlier). Of the patients classified initially as high 
risk on the Wells score, only 15% were also classified as high probability on the V/Q 
scan results. 
 
Conclusion: Of the 120 patients studied, only 15 patients (13%) turned out to have 
a high probability of PE on the VQ scan. Our study demonstrated good agreement 
between patients with low risk of PE on the Wells score compared to the low 
probability of PE on the V/Q scan results. Practically this implies that if a physician 
finds himself in a health care centre lacking a nuclear medicine facility, he may safely 
base management decisions in patients with a low pre-test risk of PE on the Wells 
score. However, there was poor agreement between the moderate and high risk 
patients compared to the intermediate and high probability of PE on the V/Q scan 
results, respectively. These patients would require a V/Q scan to guide management 
decisions.  
 
Many factors may have contributed to this poor agreement in our setting. The first 
factor is the diagnostic workup and inappropriate investigation of patients in the 
public sector hospitals. Since the patients were referred based solely on presenting 
signs and symptoms, it is possible that some patients were referred inappropriately 
for V/Q scans. We do acknowledge that this diagnosis is not always easy clinically in 
light of the non-specific signs and symptoms. It is for this very reason that clinical 
decision rules, such as the Wells prediction rule, have been developed in an attempt 
to improve implicit clinical judgement. The patients in our sample population may not 
have been referred for a V/Q scan primarily based on the Wells score. Instead, the 
Wells score was often calculated in retrospect by the investigating departments.  
 
vii 
 
Furthermore, this being a retrospective analysis, no formal diagnostic pathways were 
followed prior to requesting a V/Q scan. It seems from the results however, that 
some patients had been subjected to a V/Q scan unnecessarily, despite having a low 
pre-test probability as well as negative D-dimer results. The V/Q scan could have 
been entirely avoided in these patients and thus prevented unnecessary radiation 
exposure. A further prospective study with a larger patient base may yield more 
conclusive results.  
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